Related Experiment Videos

[Study of the activity of ambroxol in children with aspecific bronchial hyperreactivity]

M Berni Canani1, L De Luca, P Vuilleumier

  • 1SSN U.S.L. 40 Regione Campania, Presidio Ospedaliero Santobono, Napoli, Italia.

Insights

Ambroxol treatment may help children with recurrent cough and rhinitis by normalizing bronchial reactivity. This study suggests ambroxol improves the function of the bronchial mucous membrane and ciliary apparatus.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology

Context:

  • Recurrent cough and rhinitis in children can indicate underlying bronchial hyperresponsiveness.
  • Identifying and managing non-specific bronchial reactivity is crucial in pediatric respiratory care.

Purpose:

  • To evaluate the effect of ambroxol on non-specific bronchial reactivity (IBA) in children with recurrent cough/rhinitis.
  • To assess ambroxol's impact on the bronchial mucous membrane and ciliary apparatus.

Summary:

  • The study assessed methacholine-induced bronchial reactivity (IBA) before and after ambroxol treatment in children predisposed to bronchial hyperresponsiveness.
  • Allergic evaluations including Prick tests and total IgE were performed.
  • Results indicated ambroxol's potential to normalize bronchial mucous membrane function and ciliary apparatus activity.

Impact:

  • Ambroxol may offer a therapeutic option for pediatric patients experiencing recurrent respiratory symptoms linked to bronchial hyperresponsiveness.
  • Findings suggest a mechanism involving the normalization of airway mucosal and mucociliary function.

Related Concept Videos